Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Factors Associated with Attention Deficit Hyperactivity Disorder Medication Use in Community Care Settings.

Kamimura-Nishimura KI, Epstein JN, Froehlich TE, Peugh J, Brinkman WB, Baum R, Gardner W, Langberg JM, Lichtenstein P, Chen D, Kelleher KJ.

J Pediatr. 2019 Oct;213:155-162.e1. doi: 10.1016/j.jpeds.2019.06.025. Epub 2019 Jul 9.

PMID:
31300310
2.

Attention-Deficit/Hyperactivity Disorder-Related Deficits and Psychostimulant Medication Effects on Comprehension of Audiovisually Presented Educational Material in Children.

Orban SA, Karamchandani TA, Tamm L, Sidol CA, Peugh J, Froehlich TE, Brinkman WB, Estell N, Mii AE, Epstein JN.

J Child Adolesc Psychopharmacol. 2018 Aug 27. doi: 10.1089/cap.2018.0006. [Epub ahead of print]

3.

Using ADHD Medications to Treat Coexisting ADHD and Reading Disorders: A Systematic Review.

Froehlich TE, Fogler J, Barbaresi WJ, Elsayed NA, Evans SW, Chan E.

Clin Pharmacol Ther. 2018 Oct;104(4):619-637. doi: 10.1002/cpt.1192. Epub 2018 Aug 30.

4.

Sluggish Cognitive Tempo as a Possible Predictor of Methylphenidate Response in Children With ADHD: A Randomized Controlled Trial.

Froehlich TE, Becker SP, Nick TG, Brinkman WB, Stein MA, Peugh J, Epstein JN.

J Clin Psychiatry. 2018 Mar/Apr;79(2). pii: 17m11553. doi: 10.4088/JCP.17m11553.

5.

Multimodal Treatment of the School-aged Child With Attention-Deficit/Hyperactivity Disorder.

Froehlich TE, Brinkman WB.

JAMA Pediatr. 2018 Feb 1;172(2):109-110. doi: 10.1001/jamapediatrics.2017.4023. No abstract available.

PMID:
29228151
7.

Association of Bisphenol A exposure and Attention-Deficit/Hyperactivity Disorder in a national sample of U.S. children.

Tewar S, Auinger P, Braun JM, Lanphear B, Yolton K, Epstein JN, Ehrlich S, Froehlich TE.

Environ Res. 2016 Oct;150:112-118. doi: 10.1016/j.envres.2016.05.040. Epub 2016 Jun 6.

PMID:
27281688
8.

Effects of Methylphenidate on Sleep Functioning in Children with Attention-Deficit/Hyperactivity Disorder.

Becker SP, Froehlich TE, Epstein JN.

J Dev Behav Pediatr. 2016 Jun;37(5):395-404. doi: 10.1097/DBP.0000000000000285.

9.

Association of pyrethroid pesticide exposure with attention-deficit/hyperactivity disorder in a nationally representative sample of U.S. children.

Wagner-Schuman M, Richardson JR, Auinger P, Braun JM, Lanphear BP, Epstein JN, Yolton K, Froehlich TE.

Environ Health. 2015 May 28;14:44. doi: 10.1186/s12940-015-0030-y.

10.

Expanding medication options for pediatric ADHD.

Froehlich TE, Delgado SV, Anixt JS.

Curr Psychiatr. 2013 Dec;12(12):20-29. No abstract available.

11.

Association of attention-deficit/hyperactivity disorder and conduct disorder with early tobacco and alcohol use.

Brinkman WB, Epstein JN, Auinger P, Tamm L, Froehlich TE.

Drug Alcohol Depend. 2015 Feb 1;147:183-9. doi: 10.1016/j.drugalcdep.2014.11.018. Epub 2014 Dec 2.

12.

Uncovering a clinical portrait of sluggish cognitive tempo within an evaluation for attention-deficit/hyperactivity disorder: A case study.

Becker SP, Ciesielski HA, Rood JE, Froehlich TE, Garner AA, Tamm L, Epstein JN.

Clin Child Psychol Psychiatry. 2016 Jan;21(1):81-94. doi: 10.1177/1359104514554312. Epub 2014 Oct 17.

13.

[A brief introduction to the 2013 annual conference of Pediatric Academic Societies in the United States].

Chen L, Te F, Jn E, Zhao X, Yu J, Xu Z, Li T.

Zhonghua Er Ke Za Zhi. 2014 Jan;52(1):75-7. Chinese. No abstract available.

PMID:
24680418
14.

Mediators of methylphenidate effects on math performance in children with attention-deficit hyperactivity disorder.

Froehlich TE, Antonini TN, Brinkman WB, Langberg JM, Simon JO, Adams R, Fredstrom B, Narad ME, Kingery KM, Altaye M, Matheson H, Tamm L, Epstein JN.

J Dev Behav Pediatr. 2014 Feb-Mar;35(2):100-7. doi: 10.1097/DBP.0000000000000025.

15.

National trends in psychotropic medication use in young children: 1994-2009.

Chirdkiatgumchai V, Xiao H, Fredstrom BK, Adams RE, Epstein JN, Shah SS, Brinkman WB, Kahn RS, Froehlich TE.

Pediatrics. 2013 Oct;132(4):615-23. doi: 10.1542/peds.2013-1546. Epub 2013 Sep 30.

16.

A discriminative analytical method for detection of CES1A1 and CES1A2/CES1A3 genetic variants.

Zhu HJ, Brinda B, Froehlich TE, Markowitz JS.

Pharmacogenet Genomics. 2012 Mar;22(3):215-8. doi: 10.1097/FPC.0b013e32834f03eb.

17.

Characteristics of successful recruitment in prospective pediatric pharmacogenetic studies.

SaldaƱa SN, Hooper DK, Froehlich TE, Campbell KM, Prows CA, Sadhasivam S, Nick TG, Seid M, Vinks AA, Glauser TA.

Clin Ther. 2011 Dec;33(12):2072-81. doi: 10.1016/j.clinthera.2011.10.026. Epub 2011 Dec 2.

18.

Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.

Froehlich TE, Epstein JN, Nick TG, Melguizo Castro MS, Stein MA, Brinkman WB, Graham AJ, Langberg JM, Kahn RS.

J Am Acad Child Adolesc Psychiatry. 2011 Nov;50(11):1129-1139.e2. doi: 10.1016/j.jaac.2011.08.002. Epub 2011 Sep 15.

19.

Update on environmental risk factors for attention-deficit/hyperactivity disorder.

Froehlich TE, Anixt JS, Loe IM, Chirdkiatgumchai V, Kuan L, Gilman RC.

Curr Psychiatry Rep. 2011 Oct;13(5):333-44. doi: 10.1007/s11920-011-0221-3. Review.

20.

Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.

Froehlich TE, McGough JJ, Stein MA.

CNS Drugs. 2010 Feb;24(2):99-117. doi: 10.2165/11530290-000000000-00000. Review.

21.

Association of tobacco and lead exposures with attention-deficit/hyperactivity disorder.

Froehlich TE, Lanphear BP, Auinger P, Hornung R, Epstein JN, Braun J, Kahn RS.

Pediatrics. 2009 Dec;124(6):e1054-63. doi: 10.1542/peds.2009-0738. Epub 2009 Nov 23.

22.

Association of environmental toxicants and conduct disorder in U.S. children: NHANES 2001-2004.

Braun JM, Froehlich TE, Daniels JL, Dietrich KN, Hornung R, Auinger P, Lanphear BP.

Environ Health Perspect. 2008 Jul;116(7):956-62. doi: 10.1289/ehp.11177.

23.

Assessing children with ADHD in primary care settings.

Langberg JM, Froehlich TE, Loren RE, Martin JE, Epstein JN.

Expert Rev Neurother. 2008 Apr;8(4):627-41. doi: 10.1586/14737175.8.4.627. Review.

PMID:
18416664
24.

The time and change test: a simple screening test for dementia.

Inouye SK, Robison JT, Froehlich TE, Richardson ED.

J Gerontol A Biol Sci Med Sci. 1998 Jul;53(4):M281-6.

PMID:
18314567
25.

Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children.

Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS.

Arch Pediatr Adolesc Med. 2007 Sep;161(9):857-64.

PMID:
17768285
26.

Interactive effects of a DRD4 polymorphism, lead, and sex on executive functions in children.

Froehlich TE, Lanphear BP, Dietrich KN, Cory-Slechta DA, Wang N, Kahn RS.

Biol Psychiatry. 2007 Aug 1;62(3):243-9. Epub 2007 Jan 17.

PMID:
17239353
27.

Dementia and race: are there differences between African Americans and Caucasians?

Froehlich TE, Bogardus ST Jr, Inouye SK.

J Am Geriatr Soc. 2001 Apr;49(4):477-84. Review.

PMID:
11347796
28.

Screening for dementia in the outpatient setting: the time and change test.

Froehlich TE, Robison JT, Inouye SK.

J Am Geriatr Soc. 1998 Dec;46(12):1506-11.

PMID:
9848810

Supplemental Content

Loading ...
Support Center